About Careers MedBlog Contact us

Top Drug Company Agrees to $2.4 Billion Settlement for Diabetes Drug Suits

by Julia Samuel on April 29, 2015 at 3:32 PM
Font : A-A+

Top Drug Company Agrees to $2.4 Billion Settlement for Diabetes Drug Suits

Takeda Pharmaceutical, the top Japanese drug maker, agreed to pay around $2.4 billion to settle lawsuits which raised claims over Actos diabetes drug to have risk of cancer.

The agreement would resolve lawsuits representing some 8,000 people who used the treatment for type 2 diabetes beginning in the late 1990s and claimed the company did not warn them that it increases the risks of cancer.


Takeda said that it agreed to pay out $2.37 billion if 95% of the litigants agree to the deal, rising to $2.4 billion if the number rises to 97% or more. It believes the claims of the litigants "are without merit and does not admit liability."

"Takeda believes the company acted responsibly with regard to Actos and that Actos has a positive benefit/risk profile for the treatment of type 2 diabetes," it said.

Takeda said the settlement does not change its continued commitment to Actos, or pioglitazone hydrochloride. Actos continues to be available as a treatment option in the US, Japan and other countries.

Last year a federal jury in Louisiana ordered Takeda and US-based Eli Lilly & Co to pay a combined $9 billion in punitive damages to a patient who said Actos had caused his bladder cancer. A judge later slashed the payout to $36.8 million.

Eli Lilly was Takeda's US marketing and sales partner until 2006, with the US firm keeping the rights to sell Actos in parts of Asia and Europe, as well as in Canada and Mexico. Takeda said it was taking a $2.7 billion charge in its fourth quarter earnings to cover the settlement and related costs.

"The settlement will reduce financial uncertainties for the company and provides a significant degree of assurance toward resolving a high percentage of the Actos product liability claims," it said.

Source: Medindia


Recommended Reading

Latest Drug News

Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Top Drug Company Agrees to $2.4 Billion Settlement for Diabetes Drug Suits Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests